Navigation Links
Decision Resources Group Acquires Relay Technology Management

BURLINGTON, Mass. and CAMBRIDGE, Mass., Jan. 7, 2014 /PRNewswire/ -- Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced today that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry. The acquisition of Cambridge, Mass.-based Relay by Burlington, Mass.-based Decision Resources Group is a significant strategic step in Decision Resources Group's effort to supply its clients with premier data analytics through delivery systems that most fit their needs.

Jim Lang, CEO of Decision Resources Group said, "This important acquisition brings us three things, 1) exciting products for early stage pipeline analysis, drug target evaluation, and KOL identification, 2) a world class data and analytics leadership team, and 3) proprietary natural language processing technology, healthcare ontology, and scalable data and insight visualization platform to allow us to introduce new products and services much more quickly to our clients and to enhance our current high-value offerings."

Relay's concentration in the life-sciences industry means they are familiar with the various disparate databases and information sources that Decision Resources Group's pharmaceutical and medtech clients work with on a regular basis. They offer a way to organize and synthesize these data sets to service a multitude of organizational users.

"With Relay's ability to make sense of disparate structured and unstructured data, we can then layer on the 'so-what' insights from our premier analysts to add value to those data views – this will allow our clients to have a level of intelligence that is second-to-none in the industry," continued Mr. Lang.

"We look forward to applying our next-generation, interactive data analytics platform to Decision Resources Group's strong multidimensional offering known for top-level analysis and insight," said Brigham Hyde, CEO of Relay Technology Management. "Together, Decision Resources Group and Relay will deliver the type of data-driven solutions and predictive analytics that is critical to the current competitive environment of today's biopharma and device organizations."

Relay will move to Decision Resources Group's corporate office location in Burlington, Mass.

About Relay Technology Management
Relay Technology Management is a life sciences business intelligence and analytical software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will led to increased efficiency in drug and device development. Data-driven decision-making is the key to delivering novel, cost effective, and efficacious care to patients worldwide. For more information on Relay, please visit:

About Decision Resources Group
Decision Resources, Inc. is a world leader in high-value data, analytics and advisory services designed to help clients shape strategy, allocate resources and master their chosen markets. For more information, please visit

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall
Decision Resources Group

SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
2. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
3. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
4. Neural implant recovers ability to make decisions
5. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
6. Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms, New Webinar Hosted by Xtalks
7. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
8. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
9. Advancing Preclinical Predictions, Making Faster Clinical Decisions with Cancer Models and Preclinical Imaging - World Pharma Congress this June in Philadelphia
10. Computational Analysis in Clinical and Preclinical Decision-Making, new webinar hosted by Xtalks
11. ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
Post Your Comments:
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... the explosion of technology-enabled health and wellness, and the ... book, The Internet of Healthy Things ... or smartphones even existed, Dr. Kvedar, vice president, Connected ... health care delivery, moving care from the hospital or ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):